The Trump administration has paid a higher price than any other country to purchase Remdesivir for the United States, The Guardian reported.
Recently, Gilead Sciences has just announced a course of special treatment of Covid-19, which costs more than 3,000 USD. The drug used is Remdesivir manufactured by the company, exclusively.
This is the first US drug licensed to treat Covid-19. And the first 140,000 doses were given for trial use. Previously, this drug was manufactured to treat Ebola.
However, in the next 3 months, most countries in the world will not have the opportunity to access this medicine. Currently, the US government has purchased all the Remdesivir drugstore in July. In the next two months, the country also purchased 90% of the goods. A total of 3 months, the administration of President Donald Trump bought 500,000 doses.
“President Trump has made an impressive deal to ensure Americans have access to first licensed therapies. The US government will do everything in its power to learn ways to save Covid-19 patients and ensure Americans have access to those options, ”said US Secretary of Health and Human Services, Alex Azar , for or.
The British Health Minister said Remdesivir has been a major step in treating Covid-19 patients since the pandemic.
"People who are infected in the UK and other countries will not have the opportunity to have access to treatment that will help them leave the hospital earlier, have a higher chance of living," said Dr. Andrew Hill, University of Liverpool (UK), for good.
Low- and middle-income countries may produce other versions of the drug. However, they were unable to sell the source of the drug because it was copyrighted by Gilead.
The acquisition of almost all global Remdesivir drugs once again proves Trump's "America first" view, according to The Guardian.